<scp>ADN</scp>‐1184 a monoaminergic ligand with 5‐<scp>HT</scp>_6/7receptor antagonist activity: pharmacological profile and potential therapeutic utility

ADN-1184 combines antipsychotic-like with antidepressant-like properties without interfering with memory function or locomotion. This profile is better than that of commonly used atypical antipsychotics tested under the same conditions and suggests that it is feasible to identify drugs that improve BPSD, without exacerbating cognitive deficit or movement impairment, which are of particular concern in patients with dementia.